» Authors » Matthew L Boisen

Matthew L Boisen

Explore the profile of Matthew L Boisen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 163
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Smither A, Koninga J, Kanneh F, Foday M, Boisen M, Bond N, et al.
medRxiv . 2023 Mar; PMID: 36993465
Background: Lassa fever (LF) is a rodent-borne disease endemic to West Africa. In the absence of licensed therapeutics or vaccines, rodent exclusion from living spaces remains the primary method of...
2.
Fears A, Beddingfield B, Chirichella N, Slisarenko N, Killeen S, Redmann R, et al.
PLoS Pathog . 2022 Jul; 18(7):e1010618. PMID: 35789343
The novel coronavirus SARS-CoV-2 emerged in late 2019, rapidly reached pandemic status, and has maintained global ubiquity through the emergence of variants of concern. Efforts to develop animal models have...
3.
Borrega R, Nelson D, Koval A, Bond N, Heinrich M, Rowland M, et al.
Viruses . 2021 Nov; 13(11). PMID: 34835131
Many countries in sub-Saharan Africa have experienced lower COVID-19 caseloads and fewer deaths than countries in other regions worldwide. Under-reporting of cases and a younger population could partly account for...
4.
Botti-Lodovico Y, Nair P, Nosamiefan D, Stremlau M, Schaffner S, Agignoae S, et al.
Viruses . 2021 Aug; 13(8). PMID: 34452470
While investigating a signal of adaptive evolution in humans at the gene LARGE, we encountered an intriguing finding by Dr. Stefan Kunz that the gene plays a critical role in...
5.
Drouin A, Theberge M, Liu S, Smither A, Flaherty S, Zeller M, et al.
Viruses . 2021 Jul; 13(7). PMID: 34201591
A 59-year-old male with follicular lymphoma treated by anti-CD20-mediated B-cell depletion and ablative chemotherapy was hospitalized with a COVID-19 infection. Although the patient did not develop specific humoral immunity, he...
6.
Shaffer J, Schieffelin J, Momoh M, Goba A, Kanneh L, Alhasan F, et al.
Microorganisms . 2021 Apr; 9(3). PMID: 33809204
Lassa fever (LF) is a viral hemorrhagic disease found in Sub-Saharan Africa and is responsible for up to 300,000 cases and 5000 deaths annually. LF is highly endemic in Sierra...
7.
Heinrich M, Boisen M, Nelson D, Bush D, Cross R, Koval A, et al.
Sci Rep . 2020 Sep; 10(1):16030. PMID: 32994446
Lassa virus (LASV) is the causative agent of Lassa fever, an often-fatal hemorrhagic disease that is endemic in West Africa. Seven genetically distinct LASV lineages have been identified. As part...
8.
Boisen M, Uyigue E, Aiyepada J, Siddle K, Oestereich L, Nelson D, et al.
Sci Rep . 2020 May; 10(1):8724. PMID: 32457420
Lassa virus (LASV) is the causative agent of Lassa fever (LF), an often-fatal hemorrhagic disease. LF is endemic in Nigeria, Sierra Leone and other West African countries. Diagnosis of LASV...
9.
Boisen M, Hartnett J, Shaffer J, Goba A, Momoh M, Sandi J, et al.
Sci Rep . 2018 Apr; 8(1):5939. PMID: 29651117
Lassa fever, a hemorrhagic fever caused by Lassa virus (LASV), is endemic in West Africa. It is difficult to distinguish febrile illnesses that are common in West Africa from Lassa...
10.
Cross R, Boisen M, Millett M, Nelson D, Oottamasathien D, Hartnett J, et al.
J Infect Dis . 2016 Sep; 214(suppl 3):S210-S217. PMID: 27587634
Background: Ebola virus disease (EVD) is a severe viral illness caused by Ebola virus (EBOV). The 2013-2016 EVD outbreak in West Africa is the largest recorded, with >11 000 deaths....